December 2, 2012
Key biological mechanism in multiple sclerosis identified
- /
- /
Published: Saturday, Dec 1, 2012,Place: London | Agency: ANI US scientists have defined for the first time a key underlying…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
December 2, 2012
Cognitive Impairment in Multiple Sclerosis – A Forgotten Disability Remembered
- /
- /
By Kristen Rahn, Ph.D., Barbara Slusher, M.B.A., Ph.D., and Adam Kaplin, M.D., Ph.D.November 30, 2012 Cognitive Impairment in MS: An Overview Although…
November 30, 2012
MS Patients’ Driving Capability Assessed
- /
A simple, accurate testing protocol to determine driving fitness in individuals withmultiple sclerosis is the aim of a three-year study at…
November 30, 2012
The anticipation of the holidays can be either exciting or stressful.
- /
- /
AN EMPOWERED SPIRIT – written by: Cathy Chester Thanksgiving is over and the Christmas season has begun. The anticipation of…
November 28, 2012
MS VIEWS AND NEWS PROVIDES EDUCATIONAL INFORMATION TO THE GLOBAL MS COMMUNITY
- /
TO SEE WHAT MS VIEWS AND NEWS PROVIDES, LOCALLY, NATIONALLY AND INTERNATIONALLY, PLEASE CLICK THIS LINK TO OPEN OUR FLYER:…
November 28, 2012
Multiple sclerosis – possible trigger for nerve damage
- /
by Anil KumarHigh-resolution real-time images show in mice how nerves may be damaged during the earliest stages of multiple sclerosis.…
November 28, 2012
Cyclosporine And Tacrolimus Combination Proves Effective In The Treatment Of Multiple Sclerosis
- /
November 26, 2012 A new substance class for the treatment of multiple sclerosis and other neurodegenerative diseases now promises increased…
November 27, 2012
Positivity is key to dealing with MS
- /
- /
Alex Evans, Reporter – Sunday, November 25, 2012 ‘YOU either adapt or you go under’, says one multiple sclerosis (MS) sufferer…
November 27, 2012
Apitope announces completion of recruitment in ATX-MS-1467 Phase I trial for MS
- /
November 26th, 2012 Apitope, the European drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today…
November 27, 2012
Combination of two pharmaceuticals proves effective in the treatment of multiple sclerosis
- /
Bonn/Magdeburg/Halle, 26/11/2012. A new substance class for the treatment of multiple sclerosis and other neurodegenerative diseases now promises increased efficacy…
